Brazil introduces higher Mounjaro doses for diabetes and obesity treatment

uol.com.br (Portuguese)

Brazil will receive higher doses of Mounjaro, a medication for type 2 diabetes and obesity, in September and October. The new 7.5 mg and 10 mg Mounjaro pens will offer more treatment options for patients, with prices ranging from R$3,175 to R$3,645 before discounts. Mounjaro, containing tirzepatide, requires a prescription and is administered weekly via injection, with potential side effects like nausea.


With a significance score of 1.4, this news ranks in the top 40% of today's 30683 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Brazil introduces higher Mounjaro doses for diabetes and obesity treatment | News Minimalist